Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3031 per EA under NDC 31722016401. Its NADAC has been published 253 times since Oct 20, 2021.
FDA first approved this application on Apr 22, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 30 MG TAB
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722016401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA213709FDA Approved
4/22/2021
TE Code
AB
On Market Since
5/10/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 253 times since Oct 20, 2021, and over the history we have for it it has declined 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3031 per EA |
|---|---|
| All-time high | $0.3587 (Aug 16, 2023) |
| All-time low | $0.2416 (Jul 17, 2024) |
| 52-week high | $0.3250 |
| 52-week low | $0.2992 |
| Median price | $0.3124 |
| Average price | $0.3119 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 253 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.3031 per EA (NDC 31722016401), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 13.4%. It has been tracked across 253 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Oct 20, 2021, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.3587 (Aug 16, 2023), with a median of $0.3124 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 31722016401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.